Adocia

Research Adocia (ADOC) on Bullrun: market cap EUR 81.00M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerADOC
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 81.00M
• Financial periodFY2025
• RevenueEUR 1.48M
• Revenue growth-84.2%
• Net income-EUR 16.59M

Valuation Snapshot

latest market cap is EUR 81.00M.

About Adocia

Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company provides BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid prandial insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro;

Frequently asked questions

What is Adocia's market cap?

Adocia's market capitalization is EUR 81.00M.

What does Adocia do?

Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins.